Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Undisclosed
Sponsor : Sandoz B2B
Deal Size : $640.0 million
Deal Type : Partnership
Details : The partnership sets out highest ambitions for reaching highest quality and lowest cost levels by introducing Just – Evotec Biologics’ data-driven, fully integrated design capability and continuous manufacturing technology (J.DESIGN) into the field o...
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
May 09, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Undisclosed
Sponsor : Sandoz B2B
Deal Size : $640.0 million
Deal Type : Partnership
Lead Product(s) : Monoclonal Antibody
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : Department of Defense
Deal Size : $49.9 million
Deal Type : Agreement
Details : Under the contract, Just – Evotec Biologics will develop mAb-based drug product prototype(s) from sequence discovery or evaluation of existing mAbs to completion of Phase I first-in-human (“FIH”) clinical trials.
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
September 20, 2022
Lead Product(s) : Monoclonal Antibody
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : Department of Defense
Deal Size : $49.9 million
Deal Type : Agreement
LOOKING FOR A SUPPLIER?
Reset All
